Evidence map›Paper›PMID 38586829›Full record

ArticleFrontiers in aging neuroscience2024

Associative role of

Raoli He, Yuqi Zeng, Chaodong Wang, Lina Chen, Guoen Cai, Ying Chen, Yingqing Wang, Qinyong Ye, Xiaochun Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in aging neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Raoli He *Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Yuqi Zeng *Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Chaodong Wang *Department of Neurology, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, Beijing, China.
Lina ChenFujian Key Laboratory of Molecular Neurology and Institute of Neuroscience, Fujian Medical University, Fuzhou, China.
Guoen CaiDepartment of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Ying ChenDepartment of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Yingqing WangDepartment of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Qinyong YeDepartment of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Xiaochun ChenFujian Key Laboratory of Molecular Neurology and Institute of Neuroscience, Fujian Medical University, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Previous genome-wide association studies investigating the relationship between the Methods: The study consisted of three parts: a case-control study, a cross-sectional study, and a longitudinal cohort study. The case-control study included 477 PD patients and 477 healthy controls to explore the relationship between rs660895 and PD susceptibility. The cross-sectional study utilized baseline data from 429 PD patients to examine the correlation between rs660895 and PD features. The longitudinal study included 388 PD patients who completed a 3-year follow-up to investigate the effects of rs660895 on PD progression. Results: In the case-control study, Conclusion: Our findings support

Indexed as

disease progressiondisease susceptibilityHLA-DRB1Parkinson’s diseasesingle nucleotide polymorphism

Identifiers

PMID38586829
PMCPMC10995924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.